Behavioral Symptoms: Clinical Trials

92 trials for Behavioral Symptoms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

47 completed, 12 unknown, 10 recruiting, 9 withdrawn. 92 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 192Completed 47, Unknown 12, Recruiting 10, Withdrawn 9, Not yet recruiting 6, Terminated 6, Active not recruiting 2

Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms

Trials (filtered) newest first · largest first

All 92 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS Trial
Guanfacine (GFC), Cromolyn Sodium, Placebo - Postural Orthostatic Tachycardia Syndrome (POTS), Dysautonomia
Early Phase 1Not yet recruitingJohns Hopkins University252026-11-152026-10-09
Individualized fMRI-guided TMS for Depression
Active Repetitive Transcranial Magnetic Stimulation (rTMS), Sham Transcranial Magnetic Stimulation (TMS) - Depression, Major Depressive Disorder (MDD)
Early Phase 1Not yet recruitingUniversity of Pennsylvania602026-09-152026-09-09
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101
TMS, NRX-101 - Major Depression
Early Phase 1Not yet recruitingMclean Hospital302026-09-012026-09-22
FLOAT for Healthcare PTSS
Floatation-REST, Documentary - Posttraumatic Stress Symptoms, Burnout
Early Phase 1RecruitingLaureate Institute for Brain Research, Inc.152026-06-102026-07-17
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
repetetive transcranial magnetic stimulation - Knee Osteoarthritis, Depression
Early Phase 1RecruitingUniversity of California, Los Angeles302026-06-042026-07-06
Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
D-Cycloserine (DCS), Continuous theta-burst stimulation (cTBS), Transcranial Magnetic Stimulation Sham - Major Depression
Early Phase 1RecruitingMclean Hospital802026-03-112026-05-13
Efficacy of Digital Problem Solving Application in Reduction of Anxiety, Depression and Substance Use Disorder Symptoms
DSPT - Digital Support for Problem-solving Therapy - Anxiety, Depressive Symptoms
Early Phase 1Not yet recruiting7 Generation Games1002026-03-012024-04-04
Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study
Esketamine injection group (0.25 mg/kg), Saline injection group (Consistent with esketamine injection volume) - Esketamine, ECT
Early Phase 1RecruitingMin Su2202025-11-252026-01-07
Examining the Impact of the Parenting Young Children Check-up
The Parenting Young Children Check-up - Behavioral Health, Disruptive Behaviors
Early Phase 1RecruitingWayne State University402025-11-062026-07-29
Testing the Impact of the Parenting Young Children Check-up
Parenting Young Children Check-up - Behavioral Health, Disruptive Behaviors
Early Phase 1RecruitingWayne State University502025-11-012026-08-06
Integrating Inuit Knowledge Principles in Multi-Level Mental Health Clinical Trials
Traditional Country Foods, Cultural Workshops - Depression, Anxiety
Early Phase 1CompletedUniversity of Alberta292025-10-152026-10-23
PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm
Psilocybin 5 mg with cognitive behavioural therapy intervention, Placebo with cognitive behavioural therapy intervention - Self Harm
Early Phase 1RecruitingImperial College London302025-10-012025-12-05
Mood Effects of Serotonin Agonists: Depression
LSD, Placebo - LSD, Major Depressive Disorder
Early Phase 1CompletedUniversity of Chicago412025-06-092026-07-10
Probiotic Administration for Adolescent Depression
Visbiome, Placebo - Depression
Early Phase 1RecruitingUniversity of California, San Francisco772025-05-152026-07-14
Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients
Intranasal ketamine hydrochloride - Depressive Symptoms Mild to Moderate in Severity, Anxiety
Early Phase 1Not yet recruitingUniversity of Zurich1002025-04-012025-05-01
Effects of Cannabidiol on Burnout Syndrome and Empathy of Caregivers of Older Adults
Intervention1: Cannabidiol, Intervention 2: Placebo - Burnout Syndrome
Early Phase 1Not yet recruitingUniversity of Sao Paulo262024-12-012024-10-01
Testing a Transdiagnostic TMS Treatment Target
transcranial magnetic stimulation - Major Depressive Disorder, Depression
Early Phase 1CompletedBrigham and Women's Hospital102024-09-092026-07-13
Losartan and Emotional Learning
Losartan potassium 50mg, Placebo - Emotional Processing
Early Phase 1UnknownUniversity of Oxford602024-08-142024-10-04
Effect of Kava on Anxiety and Stress in Cancer Survivors
Kava, Placebo - Kava, Anxiety
Early Phase 1WithdrawnMasonic Cancer Center, University of Minnesota2024-06-202026-10-16
Confirmatory Efficacy Trial of Attention Bias Modification for Depression
Traditional Attention Bias Modification, Gamified Attention Bias Modification, Sham Attention Bias Modification - Depression
Early Phase 1RecruitingUniversity of Texas at Austin6002024-05-012025-09-15

Showing 20 of 92. Sign in to see all of them.

Narrower conditions

Depression (70)  ·  Anxiety Disorders (24)  ·  Depressive Disorder, Major (9)  ·  Cognitive Dysfunction (5)  ·  Pain (5)  ·  Sleep Initiation and Maintenance Disorders (5)  ·  Suicidal Ideation (5)  ·  Burnout, Psychological (4)  ·  Inflammation (4)  ·  Neoplasms (4)  ·  Occupational Stress (4)  ·  Stress Disorders, Post-Traumatic (4)  ·  Bipolar Disorder (3)  ·  Motor Activity (3)  ·  Suicide (3)

Broader conditions

Behavior (92)  ·  Mental Disorders (48)  ·  Pathological Conditions, Signs and Symptoms (21)  ·  Nervous System Diseases (18)  ·  Signs and Symptoms (18)  ·  Neurologic Manifestations (13)  ·  Mood Disorders (12)  ·  Depressive Disorder (10)  ·  Neurocognitive Disorders (9)  ·  Central Nervous System Diseases (8)  ·  Pathologic Processes (8)  ·  Stress, Psychological (8)  ·  Neoplasms (6)  ·  Neurobehavioral Manifestations (6)

Interventions

Ketamine (11)  ·  Transcranial Magnetic Stimulation (4)  ·  Endotoxins (3)  ·  Psilocybin (3)  ·  Citalopram (2)  ·  Cycloserine (2)  ·  Exercise (2)  ·  Glycopyrrolate (2)  ·  Hydrocortisone (2)  ·  Iontophoresis (2)  ·  Lipopolysaccharides (2)  ·  Midazolam (2)  ·  Sodium Chloride (2)  ·  hydrocortisone acetate (2)  ·  3-(2'-fluoro-6',7'-dihydrospiro(piperidine-4,4'-thieno(3,2-c)pyran)-1-yl)-2-(2-fluorobenzyl)-N-methylpropanamide (1)

Sponsors

University of California, Los Angeles (6)  ·  Mclean Hospital (4)  ·  Soul Medicine Institute (3)  ·  Boston University (2)  ·  China Academy of Chinese Medical Sciences (2)  ·  James J. Peters Veterans Affairs Medical Center (2)  ·  Johns Hopkins University (2)  ·  Stanford University (2)  ·  University of Texas at Austin (2)  ·  Wayne State University (2)  ·  7 Generation Games (1)  ·  Ali Rezai, MD (1)  ·  Benten Technologies, Inc. (1)  ·  Bezmialem Vakif University (1)  ·  Brigham and Women's Hospital (1)

Countries

United States (60)  ·  Canada (5)  ·  United Kingdom (4)  ·  China (3)  ·  Australia (2)  ·  Brazil (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Germany (1)  ·  Ireland (1)  ·  Israel (1)  ·  Norway (1)  ·  Philippines (1)  ·  Russia (1)  ·  Switzerland (1)

Top investigators

Christopher P Cardozo, MD (2)  ·  Dawson Church, PhD (2)  ·  Keith Sudheimer, Ph.D. (2)  ·  Scott Irwin, MD, PhD (2)  ·  Alan Stanley Apter, MD (1)  ·  Albert Garcia-Romeu, PhD (1)  ·  Ali Rezai, MD (1)  ·  Amber Leaver, PhD (1)  ·  Andrea Reinecke, PhD (1)  ·  Andreas Bechdolf, MD (1)  ·  AnnMaria Demars, Ph.D. (1)  ·  Anthony Bossis, PhD (1)  ·  Benjamin Lewis, MD (1)  ·  Cherry Leung, PhD, RN (1)  ·  Christian J Amlang, MD (1)

Results publications

PMID 16677714, PMID 19376240, PMID 20719303, PMID 21569488, PMID 22848802, PMID 23599019, PMID 23679917, PMID 25276687, PMID 25770082, PMID 26360770, PMID 26364274, PMID 26540163, PMID 27909164, PMID 27965856, PMID 29283117, PMID 29768360, PMID 31103547, PMID 31567264, PMID 31632316, PMID 31916890, PMID 32627860, PMID 32665041, PMID 34711062, PMID 35488938, PMID 35871638, PMID 36042911, PMID 36186856, PMID 36399169, PMID 36943254, PMID 36977985, PMID 37815563, PMID 39428602, PMID 39435124, PMID 39725004, PMID 40270079

NIH funding

2014 (1), K23MH101498 (1), P30AG072958 (1), R01DA002812 (1), R01MH059668 (1), R01MH091352 (1), R01MH139697 (1), R21CA197023 (1), R21MH113915 (1), R33MH135428 (1), R44MH121219 (1), R61AT012028 (1), UL1TR001412 (1)